BioIVT Appoints Jennifer Murphy as Senior Vice President of Global Commercial Operations

Westbury, NY – April 11, 2022 – BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has appointed Jennifer Murphy as Senior Vice President of Global Commercial Operations. In her new role, Jennifer will be responsible for building and growing the global commercial programs for all BioIVT’s product lines and services.


“We are delighted that Jennifer is joining BioIVT. She has a wealth of life sciences leadership and sales expertise. Jennifer shares our enthusiasm and commitment to providing a superior customer experience and continuing the mission of delighting our clients. I look forward to partnering with her as we continue to expand our business,” said BioIVT CEO Jeff Gatz.


“I am excited to join the BioIVT team because I know that what we do every day will positively impact patient outcomes. I am committed to helping my team become the best version of themselves both personally and professionally, and to demonstrating how a strong work ethic, combined with focus and determination can generate exceptional results,” said Jennifer. Jennifer joins BioIVT from Thermo Fisher Scientific where she held roles of increasing responsibility, progressing from account manager to area director and senior director to vice president of sales across five businesses in the Customer Channels, Specialty Diagnostics, and Life Sciences groups. In addition to successfully building high-performing, results-oriented teams, Jennifer served as the executive champion for the company’s Women's, African Heritage, and Working Parents Employee Resource Groups.


Prior to joining Thermo Fisher, Jennifer spent 10 years as a medical technologist and clinical laboratory director for hospital and clinic systems in the Midwest.


She has a Bachelor of Science degree in Biology and Chemistry from the University of Wisconsin – Platteville and a Master of Business Administration with an emphasis in HealthCare Administration from the University of Phoenix.


About BioIVT

BioIVT is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in control and disease-state biospecimens including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. And as the premier supplier of hepatic products, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in elevating science. For more information, please visit www.bioivt.com or follow the company on Twitter @BioIVT.


SpeeDx receives CE-IVD mark for multiplex PlexPCR® VHS test for VZV, herpes and syphilis

SYDNEY, AUSTRALIA–(October 25, 2017). SpeeDx Pty. Ltd. has announced that it has received CE-IVD ma...

Read More >


A new exhibition at the Science Museum, London will feature an invention from the Oxford area which ...

Read More >

New HORIBA Yumizen haematology analysers minimise microscopy slide reviews

Studies confirm strong analytical performance for body fluid and pathological sample analysis of HEL...

Read More >

EKF Diagnostics supporting reduction of anemia in developing regions in South America

Symposium highlights successful use of EKF’s Hemo Control hemoglobin analyzer in extreme environmen...

Read More >

A Valuable New Information Resource for Faecal Immunochemical Testing (FIT) for Bowel Cancer Detection

www.faecal-immunochemical-test.co.uk is a dedicated new website, developed by Alpha Laboratories Ltd...

Read More >

Sensitive, Reliable and Rapid Detection of Cryptococcal Infection

The IMMY CrAg® LFA (Cryptococcal Antigen Lateral Flow Assay) is the first and only immunochromatogra...

Read More >